Paul M Meister insider trades

Open-market stock purchases and sales by Paul M Meister, Director at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 31, 2009.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -48%.

Recent trades

DateStockTradeValue
May 7, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
May 6, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Apr 29, 2026APTV Aptiv plcBought (not open market)—
Apr 28, 2026APTV Aptiv plcSold (not open market)$34.9K
Apr 22, 2026VGNT Versigent plcBought (not open market)—
Jan 2, 2026QTRX Quanterix CorpBought (not open market)—

Companies traded

  • AMRX Amneal Pharmaceuticals, Inc: 2 buys, last May 7, 2026
  • APTV Aptiv plc: other filings, last Apr 29, 2026
  • VGNT Versigent plc: other filings, last Apr 22, 2026
  • QTRX Quanterix Corp: 2 buys, last Jan 2, 2026
  • TBIO Telesis Bio Inc: other filings, last Jun 6, 2023
  • SGMS Scientific Games Corp: other filings, last Jun 10, 2020
  • LKQ LKQ Corp: 1 buy, 3 sales, last May 8, 2017
  • LKQX LKQ Corp: 8 sales, last May 14, 2012
  • MFW M & F Worldwide Corp: other filings, last Dec 21, 2011

Get free alerts when Paul M Meister files a new trade →